{"product_id":"nek7-antibody-sc-f1003","title":"NEK7 Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eThe mitotic kinase NEK7 licenses NLRP3 inflammasome assembly and activation during interphase. Recent studies have identified NEK7 as crucial for NLRP3 activation through a direct NLRP3-NEK7 interaction. Due to its interaction with NEK9 during mitosis and its limited cellular quantity, NEK7 facilitates NLRP3 activation exclusively in interphase.\u003c\/p\u003e\u003cp\u003eReported cellular context includes nucleus, cytoplasm, cytoskeleton, and microtubule, which can matter when signal is compared across treatments or changing cell states. Following NEK7 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eNEK7 is commonly interpreted in the context of inflammation research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans nucleus, cytoplasm, and cytoskeleton, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between nucleus, cytoplasm, and cytoskeleton across matched conditions\u003c\/li\u003e\n\u003cli\u003eresponses associated with cytokine exposure, inflammatory tone, or tissue stress\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003cli\u003etime-matched comparisons so changes reflect biology rather than handling or sampling drift\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for NEK7. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in NEK7 reflect biology rather than handling. When interpreting NEK7, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep NEK7 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57577587835225,"sku":"F1003-20UL","price":169.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57577587867993,"sku":"F1003-100UL","price":369.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57577587900761,"sku":"F1003-2X100UL","price":549.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F1003-wb.gif?v=1773599179","url":"https:\/\/absource.de\/products\/nek7-antibody-sc-f1003","provider":"Absource Diagnostics","version":"1.0","type":"link"}